Safety and Efficacy Study of NBI-98854 in Children and Adolescents With Tourette Syndrome
Clinical trial NCT02679079 · COMPLETED
Trial details
- NCT number
- NCT02679079
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-23
- Primary completion
- 2017-04-14
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.